GLP-1 receptor agonists may aid smoking cessation by curbing cravings and mitigating weight gain, which often are impediments ...

People who use popular diabetes drugs called GLP-1 receptor agonists may be at  increased risk for a serious eye disease, a ...

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced st ...

"Our study found a similar incidence of obesity-related cancer among patients treated with first-generation glucagon-like peptide-1 receptor ... "We do not yet fully understand how GLP-1s work ...

There is substantial interest in how GLP-1RA (glucagon-like peptide-1 receptor agonists) and SGLT2 (sodium-glucose cotransporter ... to help the community appreciate the extent of ongoing work and the ...

The popularity of GLP-1 receptor agonists have prompted some trainers to offer regimens that ... More specifically deal with the side effects of the resulting rapid weight loss. Here personal ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

Each patch contains a specific dosage of 0.8 mg of SMGT-GLP-1, a glucagon-like peptide-1 receptor agonist that plays a crucial role in ... These excipients work synergistically with the active ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

The poster focuses on the linkage between Glucagon-like Peptide 1 Receptor Agonists (GLP-1s) and Suicidal Ideation ... whereas those indicated for diabetes do not. This research adds to the ...